Innovita Biological Technology Co., Ltd. (SHA:688253)

SHA:688253 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	361.9	567.09	307.73	166.46	388.67	479.74
Trading Asset Securities	1,401	1,382	1,584	1,531	1,115	87.25
Cash & Short-Term Investments	1,762	1,949	1,892	1,697	1,503	566.99
Cash Growth	-4.63%	3.03%	11.49%	12.89%	165.14%	-4.92%
Accounts Receivable	2.47	12	37.83	105.17	124.31	4.13
Other Receivables	1.9	1.85	1.95	1.68	10.63	0.27
Receivables	4.37	13.85	39.78	106.86	134.95	4.4
Inventory	46.04	57.18	43.47	61.51	74.8	43.63
Other Current Assets	5.69	6.77	22.21	7.2	24.46	32.81
Total Current Assets	1,819	2,027	1,998	1,873	1,738	647.83
Property, Plant & Equipment	119.19	128.88	120.21	118.39	130.29	116.93
Long-Term Investments	126.48	57.89	35.65	34.26	14.94	5
Goodwill	3.64	3.64	-	-	-	-
Other Intangible Assets	19.62	18.32	6.79	7.02	7.25	7.49
Long-Term Deferred Tax Assets	24.53	24.84	22.65	13.41	2.26	1.22
Long-Term Deferred Charges	11.67	7.98	11.19	8.65	12.02	7.31
Other Long-Term Assets	2.83	6.69	18.42	11.31	38.3	12.1
Total Assets	2,127	2,275	2,212	2,066	1,943	797.87

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	36.54	79.12	90.93	63.57	71.56	21.16
Accrued Expenses	15	26.74	41.94	25.37	27.44	20.31
Short-Term Debt	-	-	-	-	17.62	-
Current Portion of Leases	-	3.84	3.2	1.96	3.01	0.88
Current Income Taxes Payable	3.07	0.92	0.95	16.34	4.31	2.64
Current Unearned Revenue	19.27	83.43	57.25	100.66	105.1	5.9
Other Current Liabilities	10.84	19.56	15.94	7.34	14.06	1.27
Total Current Liabilities	89.31	213.6	210.21	215.23	243.11	52.15
Long-Term Leases	2.59	3.95	2.57	1.04	2.49	0.52
Long-Term Unearned Revenue	1.6	1.91	3.14	4.8	6.33	6.99
Long-Term Deferred Tax Liabilities	4.24	3.86	3.15	2.58	1.31	0.05
Total Liabilities	97.74	223.32	219.07	223.65	253.24	59.7

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	136.98	136.98	136.46	136.06	136.06	102.04
Additional Paid-In Capital	1,060	1,053	1,036	1,024	1,022	255.67
Retained Earnings	914.61	944.18	874.94	682.51	531.15	380.46
Treasury Stock	-78.01	-78.01	-50.01	-	-	-
Comprehensive Income & Other	-5.08	-4.18	-3.65	-1.02	-	-
Total Common Equity	2,029	2,052	1,993	1,842	1,689	738.17
Shareholders' Equity	2,029	2,052	1,993	1,842	1,689	738.17
Total Liabilities & Equity	2,127	2,275	2,212	2,066	1,943	797.87

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	7.19	7.78	5.77	3	23.12	1.4
Net Cash (Debt)	1,755	1,942	1,886	1,694	1,480	565.59
Net Cash Growth	-4.83%	2.93%	11.35%	14.45%	161.71%	-3.73%
Net Cash Per Share	12.91	14.25	13.83	12.47	12.18	5.55
Filing Date Shares Outstanding	135.13	134.87	134.87	136.06	136.06	102.04
Total Common Shares Outstanding	135.13	134.87	134.87	136.06	136.06	102.04
Working Capital	1,729	1,814	1,787	1,657	1,494	595.68
Book Value Per Share	15.01	15.21	14.78	13.54	12.42	7.23
Tangible Book Value	2,006	2,030	1,987	1,835	1,682	730.68
Tangible Book Value Per Share	14.84	15.05	14.73	13.49	12.36	7.16
Buildings	-	105.12	97.96	97.96	94.67	85.39
Machinery	-	112.92	98.21	86.21	77.17	61.21
Construction In Progress	-	3.68	2.37	-	-	0.2

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error